Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 14.3.2025Apta Medica Internacional d.o.o. (AWP)7328ETigecycline AptaPharma 50 mg prášok na infúzny roztok (plv ifo 10x50 mg (liek.inj.skl.))5.3.2025U
 14.3.2025Fresenius Kabi Deutschland GmbH (FRK-1)1184DIdacio 40 mg injekčný roztok v naplnenom pere (sol inj 2x0,8 ml/40 mg (striek.inj.napl.skl. v pere - Physioject))20.3.2025O
 14.3.2025Fresenius Kabi Deutschland GmbH (FRK-1)7704EOtulfi 90 mg injekčný roztok naplnený v injekčnej striekačke (sol inj 1x1 ml/90 mg (striek.inj.napl.skl.))20.3.2025U
 14.3.2025Fresenius Kabi Deutschland GmbH (FRK-1)7703EOtulfi 45 mg injekčný roztok naplnený v injekčnej striekačke (sol inj 1x0,5 ml/45 mg (striek.inj.napl.skl.))20.3.2025U
 14.3.2025Fresenius Kabi Deutschland GmbH (FRK-1)7705EOtulfi 130 mg koncentrát na infúzny roztok (con inf 1x26 ml/130 mg (liek.inj.skl.))20.3.2025U
 14.3.2025Fresenius Kabi Deutschland GmbH (FRK-1)5269EAzacitidine Kabi 25 mg/ml prášok na injekčnú suspenziu (plv inu 1x100 mg (liek.inj.skl.))20.3.2025U
 14.3.2025Zentiva, k.s. (ZNT-1)2516DZetovar 10 mg/80 mg tablety (tbl 30x10 mg/80 mg (blis.OPA/Al/PVC))18.3.2025O
 14.3.2025Zentiva, k.s. (ZNT-1)2517DZetovar 10 mg/80 mg tablety (tbl 90x10 mg/80 mg (blis.OPA/Al/PVC))18.3.2025O
 14.3.2025Zentiva, k.s. (ZNT-1)2513DZetovar 10 mg/40 mg tablety (tbl 90x10 mg/40 mg (blis.OPA/Al/PVC))18.3.2025O
 14.3.2025Zentiva, k.s. (ZNT-1)9996DLevosimendan Zentiva (con inf 1x5 ml/12,5 mg (liek.skl.inj.))14.3.2025O
 14.3.2025Takeda Pharma A/S (TAA-2)55560Xefo 8 mg filmom obalené tablety (tbl flm 50x8 mg (blis.PVC/Al))14.3.2025R
 14.3.2025BAUSCH HEALTH IRELAND LIMITED (BAU-3)42081SUPRELIP (cps dur 100x200 mg (blis. PVC/Al))14.3.2024U
 14.3.2025Accord Healthcare S.L.U (ACC-ES)7613ENilotinib Accord 200 mg tvrdé kapsuly (cps dur 120(3x40x1)x200 mg (blis.PVC/PVDC/Al - jednotk.multibal.))12.3.2025U
 13.3.2025GlaxoSmithKline (Ireland) Limited (GAG-IE-2)13975Flixotide 250 Inhaler N (sus inh 1x120 dávok (nád.tlak.Al))13.3.2025R
 13.3.2025Astellas Pharma Europe B.V. (ASL-2)8499DEvrenzo 150 mg filmom obalené tablety (tbl flm 12x1x150 mg (blis.PVC/Al - jednotk.bal.))13.3.2025O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)